PSMT Form 4: David Price Receives 73,551 Restricted Shares Vesting Through 2030
Rhea-AI Filing Summary
Pricesmart Inc. (PSMT) reporting person David R. Price, who serves as CEO and a director, received a grant of 73,551 restricted shares of common stock on 09/04/2025 with a $0 per-share price. After the grant, Mr. Price beneficially owns 122,067 shares in total, comprising 51,305 shares held indirectly by the David Price Trust. The restricted shares vest in annual installments: 15,579 shares vest on October 26 of 2026, 2027, and 2028; 15,359 shares vest on October 26, 2029; and 11,455 shares vest on October 26, 2030, all subject to continued service.
Positive
- Significant equity award of 73,551 restricted shares indicates alignment of CEO incentives with shareholder value over multiple years
- Clear multi-year vesting schedule (2026–2030) supports executive retention and long-term focus
- Substantial beneficial ownership reported (122,067 shares) including indirect holdings via the David Price Trust
Negative
- Potential dilution from issuance of 73,551 restricted shares to the CEO
- Grant priced at $0 (per Form 4) implies compensation expense without disclosed offsetting performance conditions
Insights
TL;DR: CEO received multi-year restricted stock award that ties compensation to continued service and long-term ownership.
The award of 73,551 restricted shares spread over five annual vesting dates strengthens executive alignment with shareholders by converting compensation into equity that vests over 2026–2030. The grant increases the reporting person’s beneficial ownership to 122,067 shares, with a portion held indirectly via a trust. From a governance perspective, multi-year vesting schedules reduce short-term turnover risk and signal retention intent. The filing is routine under Section 16 reporting requirements and does not disclose additional performance conditions beyond continued service.
TL;DR: The Form 4 discloses a standard restricted stock award; market impact is likely minimal absent other disclosures.
The transaction shows an award priced at $0 and scheduled to vest in specified tranches through October 26, 2030, indicating compensation rather than open-market purchase or sale. Beneficial ownership after the grant is 122,067 shares, including 51,305 indirect shares via the David Price Trust. The filing does not provide company-level metrics, valuation, or accounting treatment, so material financial impact cannot be quantified from this Form 4 alone.